Showing results (71-80 of 240) with videos related to
Sort By:
Pageof 24
Chemmedchem|September 5, 2015
Tetrazolylhydrazides as Selective Fragment-Like Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4ANicole Rüger, Martin Roatsch, Thomas Emmrich, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 7, 2009
Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching techniqueWerner Neubauer, Armin König, Richard Bolek, et al.Plos One|October 3, 2012
High-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin bindingAdam Yasgar, Silviya D Furdas, David J Maloney, et al.Cancer Biology & Therapy|March 13, 2014
Limited efficacy of specific HDAC6 inhibition in urothelial cancer cellsLorena Rosik, Günter Niegisch, Ute Fischer, et al.International Journal of Molecular Sciences|April 28, 2023
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated LysinesMatthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.International Journal of Cancer|January 19, 2007
Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhoodSarah E Furchert, Claudia Lanvers-Kaminsky, Heribert Juürgens, et al.Cellular and Molecular Life Sciences : CMLS|October 17, 2021
Kappa but not delta or mu opioid receptors form homodimers at low membrane densitiesKristina Cechova, Chenyang Lan, Matus Macik, et al.The Journal of Biological Chemistry|October 10, 2003
Identification of selective inhibitors of NAD+-dependent deacetylases using phenotypic screens in yeastMaki Hirao, Jeffrey Posakony, Melisa Nelson, et al.Molecular Oncology|August 21, 2012
The role of histone demethylases in cancer therapyInga Hoffmann, Martin Roatsch, Martin L Schmitt, et al.Pageof 24